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Machine learning is proving invaluable across disciplines. How-
ever, its success is often limited by the quality and quantity of
available data, while its adoption is limited by the level of trust
afforded by given models. Human vs. machine performance is
commonly compared empirically to decide whether a certain task
should be performed by a computer or an expert. In reality, the
optimal learning strategy may involve combining the complemen-
tary strengths of humans and machines. Here, we present expert-
augmented machine learning (EAML), an automated method that
guides the extraction of expert knowledge and its integration into
machine-learned models. We used a large dataset of intensive-care
patient data to derive 126 decision rules that predict hospital
mortality. Using an online platform, we asked 15 clinicians to
assess the relative risk of the subpopulation defined by each rule
compared to the total sample. We compared the clinician-assessed
risk to the empirical risk and found that, while clinicians agreed
with the data in most cases, there were notable exceptions where
they overestimated or underestimated the true risk. Studying the
rules with greatest disagreement, we identified problems with the
training data, including one miscoded variable and one hidden
confounder. Filtering the rules based on the extent of disagreement
between clinician-assessed risk and empirical risk, we improved
performance on out-of-sample data and were able to train with less
data. EAML provides a platform for automated creation of problem-
specific priors, which help build robust and dependable machine-
learning models in critical applications.
machine learning | medicine | computational medicine
Machine-learning (ML) algorithms are proving increasinglysuccessful in a wide range of applications but are often
data inefficient and may fail to generalize to new cases. In con-
trast, humans are able to learn with significantly less data by using
prior knowledge. Creating a general methodology to extract and
capitalize on human prior knowledge is fundamental for the future
of ML. Expert systems, introduced in the 1960s and popularized
in the 1980s and early 1990s, were an attempt to emulate human
decision-making in order to address artificial intelligence problems
(1). They involved hard-coding multiple if–then rules laboriously
designed by domain experts. This approach proved problematic
because a very large number of rules was usually required, and
no procedure existed to generate them automatically. In practice,
such methods commonly resulted in an incomplete set of rules and
poor performance. The approach fell out of favor and attention
has since been focused mainly on ML algorithms requiring little to
no human intervention. More recently, the Prognosis Research
Strategy Partnership of the United Kingdom’s Medical Research
Council has published a series of recommendations to establish a
framework for clinical predictive model development, which em-
phasize the important of human expert supervision of model
training, validation, and updating (2, 3).
Learning algorithms map a set of features to an outcome of
interest by taking advantage of the correlation structure of the
data. The success of this mapping will depend on several factors,
other than the amount of actual information present in the cova-
riates (also known as features, also known as independent vari-
ables), including the amount of noise in the data, the presence of
hidden confounders, and the number of available training ex-
amples. Lacking any general knowledge of the world, it is no
surprise that current ML algorithms will often make mistakes
that would appear trivial to a human. For example, in a classic
study, an algorithm trained to estimate the probability of death
from pneumonia labeled asthmatic patients as having a lower
risk of death than nonasthmatics (4). While misleading, the
prediction was based on a real correlation in the data: These
patients were reliably treated faster and more aggressively, as
they should, resulting in consistently better outcomes. Out of
context, misapplication of such models could lead to cata-
strophic results (if, for example, an asthmatic patient was dis-
charged prematurely or undertreated). In a random dataset
collected to illustrate the widespread existence of confounders
in medicine, it was found that colon cancer screening and ab-
normal breast findings were highly correlated to the risk of
having a stroke, with no apparent clinical justification (5).
Significance
Machine learning is increasingly used across fields to derive
insights from data, which further our understanding of the
world and help us anticipate the future. The performance of
predictive modeling is dependent on the amount and quality of
available data. In practice, we rely on human experts to per-
form certain tasks and on machine learning for others. How-
ever, the optimal learning strategy may involve combining the
complementary strengths of humans and machines. We present
expert-augmented machine learning, an automated way to auto-
matically extract problem-specific human expert knowledge and
integrate it with machine learning to build robust, dependable,
and data-efficient predictive models.
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Unfortunately, superior performance on a task as measured on
test sets derived from the same empirical distribution, is often
considered as evidence that real knowledge has been captured
by a model. In a recent study, CheXNet: Radiologist-Level
Pneumonia Detection on Chest X-Rays with Deep Learning,
investigators observed that a convolutional neural network
(CNN) outperformed radiologists in overall accuracy (6). A
subsequent study revealed that the CNN was basing some of its
predictions on image artifacts that identified hospitals with
higher prevalence of pneumonia or discriminated regular from
portable radiographs (the latter is undertaken on sicker pa-
tients), while pathology present in the image was sometimes
disregarded (7). It was also shown that performance declined
when a model trained with data from one hospital was used to
predict data from another (8).
Among the biggest challenges for ML in high-stakes applica-
tions like medicine is to automatically extract and incorporate
prior knowledge that allows ML algorithms to generalize to new
cases and learn with less data. In this study, we hypothesized that
combining the extensive prior knowledge of causal and correla-
tional physiological relationships that human experts possess
with a machine-learned model would increase model generalizability,
i.e., out-of-sample performance. We introduce expert-augmented
machine learning (EAML), a methodology to automatically ac-
quire problem-specific priors and incorporate them into an ML
model. The procedure allows training models with 1) less data
that are 2) more robust to changes in the underlying variable
distributions and 3) resistant to performance decay with time.
Rather than depending on hard-coded and incomplete rule sets,
like the early expert systems did, or relying on potentially spu-
rious correlations like current ML algorithms often do, EAML
guides the acquisition of prior knowledge to improve the final ML
model. We demonstrate the value of EAML using the Multipa-
rameter Intelligent Monitoring in Intensive Care (MIMIC) data-
set collected at the Beth Israel Deaconess Medical Center
(BIDMC) between 2001 and 2012 and released by the PhysioNet
team to predict mortality among intensive-care unit (ICU) pa-
tients (9, 10).
EAML Generates Problem-Specific Priors from Human
Domain Experts
To automate the generation of problem-specific priors, we developed
a multistep approach (see Methods and summary in Fig. 1). First,
we trained RuleFit on the MIMIC-II ICU dataset collected at the
BIDMC between 2001 and 2008 to predict hospital mortality us-
ing 17 demographic and physiologic input variables that are in-
cluded in popular ICU scoring systems (11–13). This yielded 126
rules with nonzero coefficients. Using a 70%/30% training/test
split on the 24,508 cases, RuleFit achieved a test set balanced ac-
curacy of 74.4 compared to 67.3 for a Random Forest. Previously,
Fig. 1. Overview of the methods. RuleFit involves 1) training a gradient boosting model on the input data, 2) converting boosted trees to rules by con-
catenating conditions from the root node to each leaf node, and 3) training an L1-regularized (LASSO) logistic regression model. Each rule defines a sub-
population that satisfies all conditions in the rule. Clinician experts assess the mortality risk of the subpopulation defined by each rule compared to the whole
sample on a web application. For each rule, delta ranking is calculated as the difference between the subpopulation’s empirical risk as suggested by the data
and the clinicians’ estimate. A final model is trained by reducing the influence of those rules with highest delta ranking. This forms an efficient procedure
where experts are asked to assess 126 simple rules of 3 to 5 variables each instead of assessing 24,508 cases with 17 variables each.
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Random Forest had been found to be the top performer among a
library of algorithms on the MIMIC-II dataset (14). Subsequently, a
committee of 15 clinicians at the University of California, San
Francisco, were asked to categorize the risk of the subpopulations
defined by each rule compared to the general population without
being shown the empirical risk (Fig. 2). On average, clinicians took
41 ± 19 min to answer 126 questions.
We calculated the average clinician assessment for each rule
and ranked rules by increasing perceived risk, Rankp. To check
that we were successful in acquiring valid clinical information, we
then binned the rules into five groups according to their ranking
and plotted the empirical risk by group (Fig. 3). There is a
monotonic relationship between the average clinicians’ ranking
of a rule and its empirical risk (mortality ratio), as expected.
Delta Rank Helps Discover Hidden Confounders
The mortality ratio of patients within the subpopulation defined
by each rule was used to calculate the empirical risk ranking of the
rules, Ranke. The delta ranking was defined as ΔRank = Ranke –
Rankc and is a measure of clinicians’ disagreement with the em-
pirical data. The distribution of ΔRank is shown in SI Appendix,
Fig. S1. We hypothesized that those rules where ΔRank was
outside the 90% confidence interval were likely to indicate either
that clinicians misjudged the risk of the given subpopulations or
that hidden confounders were modifying the risk. This hypothesis
is based on the fact that the rules were created by the ML model
based on empirical risk, while clinicians were estimating risk of
each subpopulation based on medical knowledge and experience.
We first analyzed those rules where the empirical ranking was
significantly lower than the clinicians’ perceived ranking (Table 1,
top). For rules 1, 3, and 4, clinicians estimated that patients with a
lower heart rate (HR) and Glasgow Coma Scale (GCS) score below
13 (in the original scale) are at higher risk than that supported by
the data. For rules 2 and 5, clinicians appeared to overestimate the
mortality risk of old age. Although it is true that older patients are
generally at higher risk (11, 12, 15), the data suggest that being
over 80 y old does not automatically increase one’s risk of death in
the ICU, if their physiology is not otherwise particularly com-
promised. Finally, the last rule in Table 1, top, indicates the discovery
of a hidden confounder: intubation status. Intubated patients,
whose responsiveness could not be assessed, were assigned the
lowest possible GCS score in the MIMIC dataset. This was
confirmed in correspondence with the PhysioNet team. Such a
score would normally suggest a gravely ill patient who is un-
responsive to external stimuli. Because the intubation status had
not been initially collected, we reconstructed the same group of
patients using MIMIC-III data and verified the miscoding (10).
Patients with a GCS less than 8 who are not intubated (n =
1,236) have a mortality risk of 0.28. Conversely, intubated pa-
tients (n = 6,493) have a much lower mortality ratio of 0.19. The
fact that intubated patients have been assigned the lowest pos-
sible GCS in the MIMIC-II dataset has largely been ignored in
the literature. It was briefly mentioned by the PhysioNet team in
the calculation of the sequential organ failure assessment (pre-
viously known as sepsis-related organ failure assessment; SOFA)
score in the MIMIC-III dataset (16).
Table 1, bottom, shows the top 5% of the rules where the
experts’ ranking is lower than the empirical ranking. Here we
find that clinicians have underestimated the influence of high
blood urea nitrogen (BUN) or high bilirubin (rules 7, 8, 10, and
11), although it is known that these variables affect mortality
(17–19). The disagreement with the rules 9 and 12 allowed us
to identify another important issue with the data: Clinicians
assigned a lower risk to patients with high ratio of arterial oxygen
partial pressure to fractional inspired oxygen (PaO2/FiO2) than is
supported by empirical data. In MIMIC-II, 54% of patients had
missing values for PaO2/FiO2. After imputation with the mean,
they were assigned a value of 332.60, which is very close to the
value used by the rules in Table 1, bottom (342.31 and 336.67,
respectively). We discovered that PaO2/FiO2 values were not
missing at random. In total, 94.2% of patients (n = 14,430) with
missing values for PaO2/FiO2 were not intubated, while 60.35%
of patients with values for PaO2/FiO2 were intubated. Patients
that were not intubated and had a PaO2/FiO2 greater than
336.67 had a mortality ratio of 0.046, which would agree with the
clinicians’ assessment. In contrast, patients that were intubated
and had a PaO2/FiO2 greater than 336.67 had a mortality ratio of
0.13. Since this is ∼60% of patients, they dominated the mortality
risk on these rules (e.g., 0.10 for the last rule on Table 1, bottom).
As such, clinicians are again estimating risk based on their un-
derstanding of the effects of PaO2/FiO2 on mortality, while the
algorithm has learned the effect of a hidden confounder; intubated
vs. not intubated. To confirm this, we predicted intubation status in
MIMIC-III patients from the other covariates and achieved 97%
Fig. 2. Example of a rule presented to clinicians. Age, GCS (1, <6; 2, 6 to 8; 3, 9 to 10; 4, 11 to 13; 5, 14 to 15), ratio of oxygen blood concentration to fractional
inspired oxygen concentration (PaO2/FiO2), and BUN concentration are the variables selected for this rule. The decision tree rules derived from gradient
boosting, e.g., age ≤ 73.65 and GCS ≤ 4, were converted to the form “median (range)”, e.g., age, 56.17 (16.01 to 73.65), for continuous variables and to the
form “mode (included levels)” for categorical variables. Rules were presented in a randomized order, one at a time. The top line (blue box) displays the values
for the subpopulation defined by the given rule. The bottom line (gray box) displays the values of the whole population. Participants were asked to assess the
risk of belonging to the defined subpopulation compared to the whole sample using a five-point system: highly decrease, moderately decrease, no effect,
moderately increase, and highly increase.
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mean accuracy using 10-fold cross-validation. This is especially
troublesome because PaO2/FiO2 was selected by Random Forest
as the most important variable in predicting mortality and was
also selected as the most important variable driving clinicians’
answers (Fig. 4). The underlying reason in each case is, how-
ever, very different, as the algorithm is using PaO2/FiO2 as a proxy of
intubation while clinicians are answering based on their understanding
of physiology.
EAML Improves Out-of-Sample Performance
The MIMIC dataset was well suited for us to test whether EAML
can make models more robust to variable shifts or decay of ac-
curacy with time. We built models combining clinicians’ answers
and the MIMIC-II dataset (collected from 2001 to 2008). We then
evaluated these models on two sets of the MIMIC-III data:
MIMIC-III1, which utilizes the same patients as in MIMIC-II
but has different values of the input variables due to recoding of
the underlying tables by the PhysioNet project, and MIMIC-
III2 (collected from 2008 to 2012), which consists of new pa-
tients treated in the 4 y that followed the acquisition of
MIMIC-II. Fig. 5A illustrates an example of a variable distri-
bution change from MIMIC-II to MIMIC-III1 (i.e., on the
same cases).
Fig. 5B illustrates the performance of models trained on 70%
of MIMIC-II and evaluated on MIMIC-II (30% random sub-
sample), MIMIC-III1, and MIMIC-III2. To demonstrate the
effect of clinicians’ knowledge, we first organized the rules into
five categories according to a histogram of the absolute value of
ΔRank, with ΔR = 0 reflecting those rules in which clinicians
agreed the most with the empirical data and 5 the least. (In this text,
we use ΔRank to refer to the difference between expert-assessed
risk and empirical risk and ΔR to refer to the same measure after
it has been cut into five bins). The effect of building different
models by serially removing rules with increasing ΔR is illus-
trated in Fig. 5B. This process can be considered as a “hard
EAML,” where those rules that disagree more than a certain threshold
are infinitely penalized (i.e., discarded) while those below the
threshold are penalized by a constant. Since these rules were
selected by RuleFit using the empirical distribution on MIMIC-
II, getting rid of rules adversely affects performance (area un-
der the curve [AUC]) in the training data and in the testing set
that originates from the same empirical distribution (Fig. 5B).
A different scenario emerges when these models are tested on
both MIMIC-III1 and MIMIC-III2. In this case, penalizing
those rules where clinicians disagree the most with the empir-
ical data improves performance. When only rules with ΔR =
0 are left (n = 53 of 126 rules), however, performance decreases
(Fig. 5B). This suggests a trade-off between using better rules to
build the models (those in which clinician agree with the em-
pirical risk) and oversimplifying the model (if only rules with
ΔR = 0 are used). Therefore, better results might be obtained if we
acquired clinicians’ answers for all 2,000 rules and not just the 126
selected by least absolute shrinkage and selection operator
(LASSO). The trade-off here is time needed to collect experts’
assessments.
Additionally, in Fig. 5C we note that models with the highest
accuracy can be obtained with half the data if clinicians’ answers
are used to limit rules used for training: models built with rules
from groups 1 and 2, i.e., where ΔR ≤ 1, saturate around 400
patients, while those built with all of the rules need around 800
patients. Wilcoxon tests comparing performance of models
trained on 6,400 cases (saturation) using only rules with ranking
difference ≤1 vs. all rules show the reduced rule set results in
significantly better AUC (W = 9, P = 0.00105) and balanced
accuracy (W = 4, P = 0.00013). This effect is not present if the
Table 1. The top 5% rules in which the clinician-perceived risk is greater (top) and less (bottom) than the empirical risk
Variables likely to have driven the response are highlighted in red. Values are shown as variable = median (range).
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Fig. 3. Mortality ratio by average clinicians’ risk ranking. Rules were binned
into quintiles based on average clinicians’ assessment. The mean empirical
risk for each quintile was plotted. Error bars indicate 1.96 * SE.
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model is trained and tested on MIMIC-III data (Fig. 5D). Fig. 5
B–D exemplifies the difficulties and limitations of selecting the
best models using cross-validated errors estimated from the empirical
distribution. Upon covariate shifts and data acquired at a dif-
ferent time (possibly reflecting new interventions and treatments,
etc.), model selection using cross-validation from the empirical
distribution is no longer optimal because spurious correlations
found in the empirical distribution are likely to change. Since
true causal knowledge does not change, our results suggest that this
knowledge is being extracted from clinicians (e.g., evaluation of
PaO2/FiO2 by clinicians). Finally, similar results can be obtained
if instead of using the hard version of EAML, we use a soft
version (SI Appendix).
Discussion
Despite increasing success and growing popularity, ML algo-
rithms can be data inefficient and often generalize poorly to
unseen cases. We have introduced EAML, the first methodology
to automatically extract problem-specific clinical prior knowl-
edge from experts and incorporate it into ML models. Related
previous work had attempted to predict risk based on clinicians’
assessment of individual cases using all available patient char-
acteristics with limited success (20). Here, in contrast, we
transformed the raw physiologic data into a set of simple rules
and asked clinicians to assess the risk of subpopulations defined
by those rules relative to the whole sample. We showed that
utilizing this extracted prior knowledge allows: 1) discovery of
hidden confounders and limitations of clinicians’ knowledge, 2)
better generalization to changes in the underlying feature dis-
tribution, 3) improved accuracy in the face of time decay, 4)
training with less data, and 5) illustrating the limitations of
models chosen using cross-validation estimated from the em-
pirical distribution. We used the MIMIC dataset from the
PhysioNet project (9) (10), a large dataset of intensive-care pa-
tients, to predict hospital mortality. We showed that EAML
allowed the discovery of a hidden confounder (intubation) that
can change the interpretation of common variables used to
model ICU mortality in multiple available clinical scoring sys-
tems—APACHE (11), SAPS II (21), or SOFA (13). Google
Scholar lists over 10,000 citations of PhysioNet’s MIMIC dataset
as of December 2018, with ∼1,600 new papers published every
year. Conclusions on treatment effect or variable importance
using this dataset should be taken with caution, especially since
intubation status can be implicitly learned from the data, as
shown in this study, even though the variable was not recorded.
Moreover, we identified areas where clinicians’ knowledge may
need evaluation and possibly further training, such as the case
where clinicians overestimated the mortality risk of old age in
the absence of other strong risk factors. Further investigation is
warranted to establish whether clinicians’ perceived risk is neg-
atively impacting treatment decisions.
We have built EAML to incorporate clinicians’ knowledge
along with its uncertainty into the final ML model. EAML is not
merely a different way of regularizing a machine-learned model
but is designed to extract domain knowledge not necessarily
present in the training data. We have shown that incorporating
this prior knowledge helps the algorithm generalize better to
changes in the underlying variable distributions, which, in this
case, happened after a rebuilding of the database by the
PhysioNet Project. We have also demonstrated that we can
train models more robust to accuracy decay with time. Pref-
erentially using those rules where clinicians agree with the
empirical data not only produces models that generalize better,
but it does so with considerably less data (n = 400 vs. n = 800).
This result can be of high value in multiple fields where data
are scarce and/or expensive to collect. We also demonstrated
the limitation of selecting models using cross-validated estimation
from within the empirical distribution. We showed that there is no
advantage in incorporating clinicians’ knowledge if the test set is
drawn from the same distribution as the training. However, when
the same model was tested in a population whose variables had
changed or that were acquired at a later time, including clinicians’
answers improved performance and made the algorithm more data
efficient.
The MIMIC dataset offered a great opportunity to demon-
strate the concept and potential of EAML. A major strength of
the dataset is the large number of cases, while one of the main
weaknesses is that all cases originated from a single hospital. We
were able to show the benefit of EAML in the context of feature
coding changes and time decay (MIMIC-III1 and MIMIC-III2).
However, proper application of EAML requires independent
training, validation, and testing sets, ideally from different in-
stitutions. Crucially, an independent validation set is required in
order to choose the best subset of rules (hard EAML) or the
lambda hyperparameter (soft EAML). If the validation set has
the same correlation structure between the covariates and out-
come as the training set, cross-validation will choose a lambda of
0 provided there are enough data points. However, if the vali-
dation set is different from the training set, then incorporating
expert knowledge will help and the tuning will result in lambda
greater than 0. This is the same for any ML model training
where hyperparameter tuning cannot be effectively performed
A B
Fig. 4. Variable importance estimated using a Random Forest model predicting mortality (A), and clinicians’ assessments (B). While PaO2/FiO2 is the most
important variable in both cases, in the former case it is used to learn intubation status, while in the latter clinicians are responding based on its physiological influence on
mortality.
Gennatas et al. PNAS | March 3, 2020 | vol. 117 | no. 9 | 4575
ST
A
TI
ST
IC
S
M
ED
IC
A
L
SC
IE
N
CE
S
by cross-validation of the training set if that set is not represen-
tative of the whole population of interest, which is most commonly
the case in clinical datasets. One of the biggest contributions of
this paper is showing the risk of using a validation set that has been
randomly subsampled from the empirical distribution and as such
contains the same correlations as the training data. Our team is
preparing a multiinstitutional EAML study to optimize the algo-
rithm for real-world applications.
Finally, this work also has implications on the interpretability
and quality assessment of ML algorithms. It is often considered
that a trade-off exists between interpretability and accuracy of
ML models (22, 23). However, as shown by Friedman and
Popescu (24), rule ensembles, and therefore EAML, are on average
more accurate than Random Forest and slightly more accurate than
Gradient Boosting in a variety of complex problems. EAML builds
on RuleFit to address the accuracy–interpretability trade-off in
ML and allows one to examine all of the model’s rule ahead of
deployment, which is essential to building trust in predictive
models.
Methods
A more complete description of the study methods is available in SI
Appendix. Briefly, we used the publicly available MIMIC ICU dataset from
the PhysioNet project to predict in-hospital mortality. The MIMIC dataset
includes two releases: MIMIC-II, collected at BIDMC between 2001 and
2008 (9), and MIMIC-III (10), which includes the MIMIC-II cases after
recoding of some variables (which resulted in distribution shifts) plus
new cases treated between 2008 and 2012. We split the data in four
groups: 1) MIMIC-II training (70% of MIMIC-II stratified on outcome); 2)
MIMIC-II testing (remaining 30% of MIMIC-II); 3) MIMIC-III1 (MIMIC-II
cases after recoding); and 4) MIMIC-III2 (new cases collected after 2008
not present in MIMIC-II). The 17 input features consisted of demo-
graphics and clinical and physiological variables included in common ICU
risk scoring systems.
The RuleFit procedure (24) was used to derive 126 decision rules made
up of three to five input variables that predict mortality. These rules
represent a transformation of the input variables to a Boolean matrix (i.e.,
True/False). For example, the rule “Age > 75 & systolic blood pressure < 80
& Glasgow Coma Scale < 10” will have a value of “1” for all patients that
match each of these conditions and “0” otherwise, thus defining a sub-
population within the full sample. The RuleFit-derived rules were uploaded
to a web application (http://www.mediforest.com/). Fifteen hospitalists and
ICU clinicians were asked to assess the relative mortality risk of patients
belonging to the subgroup defined by each rule relative to the whole
population by selecting one of five possible responses: highly decrease, 1;
moderately decrease, 2; no effect, 3; moderately increase, 4; and highly
increase, 5. Rules were ranked based on the empirical risk of their re-
spective subpopulations (Ranke) and by the mean clinician-assessed risk
(Rankp). The difference ΔRank = Rankp − Ranke was calculated to repre-
sent the extent of agreement between the empirical data and the expert
assessments and was used 1) to identify problems in the training data and
2) to regularize the final EAML model by penalizing rules with higher
disagreement. All analysis and visualization were performed using the
rtemis machine learning library (25).
Data Availability. The software used in this study is available on GitHub at
https://github.com/egenn/rtemis. The code used to perform this study along
with the rankings obtained from clinicians is available at https://github.com/
egenn/EAML_MIMIC_ICUmortality. The MIMIC dataset (9) can be obtained
after registration with the PhysioNet project (https://physionet.org/).
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